Dr. Michael Andrew Harrington, MD

Dr. Harrington practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Harrington's NPI, 1558561217, was assigned on July 20, 2007. Dr. Harrington graduated from USF Health Morsani College of Medicine in 2006. Dr. Harrington holds Florida license ME101770.

Dr. Harrington's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Harrington also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Harrington's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dr. Harrington is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Harrington to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harrington practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Harrington's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Harrington is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Harrington's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists cancerous skin growth removal and removal of damaged skin or skin graft among the conditions Dr. Harrington treats.

CMS data shows 704 Medicare services from Dr. Harrington across 16 procedure codes in 2024, for 315 Medicare patients. Medicare paid $89,398 for them.

CMS counts 315 Medicare patients who saw Dr. Harrington in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harrington's median patient age at 72, with 45% women.

In 2024, Dr. Harrington wrote 90 Medicare Part D claims for 48 patients. 93% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $143 in total drug cost. In 2021, CMS named 47 claims across 3 drugs.

Dr. Harrington accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 230 procedures of melanoma (skin cancer) excision by Dr. Harrington, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Harrington, published from 2015 to 2024. 2016 was the busiest year, with 4. The most frequent topics are Skin Neoplasms, COVID-19 and Internship and Residency. Dr. Harrington has published most often in Eplasty. Dr. Harrington's most frequent co-authors are Carl Wayne Cruse, MD, Jane L. Messina, MD and Wyatt Gregory Payne, MD.

CMS Open Payments shows 85 general payments to Dr. Harrington from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 37% of the total. Integra LifeSciences Corporation paid the most, $13,751.

Dr. Harrington graduated from USF Health Morsani College of Medicine in 2006.

Dr. Harrington is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.